sore throat on glp 1 Diabetes Distilled: GLP-1 receptor agonists associated with increased new chronic cough? GI adverse events up with

Additionally, the significant weight loss achieved with GLP-1 receptor agonists leads to changes in body composition, fluid distribution, and metabolic rate, all of which can influence cardiovascular hemodynamics

Mounjaro/Zepbound leads to a slightly greater weight lossthe average participant lost between 15 and 20% of their starting weight

J Gastroenterol Hepatol 33(1):232239

Exposure is linked to potential health risks, including disruption of hormonal and immune functions

These results rival or exceed what phentermine achieves (510% body weight loss), and the weight loss persists longer after the medication is continued